Advisors Asset Management, Inc. Enanta Pharmaceuticals Inc Transaction History

Advisors Asset Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$41.69 - $54.95 $226,751 - $298,873	-5,439 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$41.16 - $47.47 $3,498 - $4,034	-85 Reduced 1.54%	5,439 $229,000
Q3 2020 Nov 16, 2020	SELL	$43.36 - $53.53 $4,466 - $5,513	-103 Reduced 1.83%	5,524 $253,000
Q2 2020 Aug 12, 2020	SELL	$46.37 - $57.58 $2,828 - $3,512	-61 Reduced 1.07%	5,627 $283,000
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $11,020 - $16,988	-274 Reduced 4.6%	5,688 $293,000

Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $4,578 - $5,262	-79 Reduced 1.31%	5,962 $368,000
Q3 2019 Nov 14, 2019	SELL	$60.08 - $88.17 $7,810 - $11,462	-130 Reduced 2.11%	6,041 $363,000
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $177,315 - $212,320	2,181 Added 54.66%	6,171 $521,000
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $275,629 - $421,583	3,990 New	3,990 $381,000

108

21.7M

9.4K

3.3K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $279M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.